Most academic journals are researchers talking to researchers, butThe American Journal of Managed Care® (AJMC®) is typically researchers talking to the community, says Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy; director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School; and co-editor-in-chief of AJMC®.
Most academic journals are researchers talking to researchers, butThe American Journal of Managed Care® (AJMC®) is typically researchers talking to the community, says Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy; director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School; and co-editor-in-chief of AJMC®.
Transcript
What role does AJMC®play in informing stakeholders?
We live in an era of fake news. The American Journal of Managed Care® is dedicated to the true news, to holding up the bar of rigor, to look at a range of different topics related to managed care. We reject over two-thirds of the manuscripts that are submitted and we hold the ones that we accept to a high bar of academic rigor.
When folks want to know broadly what’s going on, they can turn to a lot of different sources. Many of those sources have vested interests in what they’re saying. Many of those sources haven’t actually studied rigorously what they’ve done. There’s often a notion that this is good enough information for our decision-making process. I don’t want to be too negative on that basic viewpoint, but the role of The American Journal of Managed Care® is to identify when we really have strong scientific evidence on a range of topics, that’s typically generated by academics or certainly people working as researchers, and then the journal becomes a bridge.
The audience includes academics, but it includes a much wider group of people, so we bridge sort of the research generation community and the research consumption community. Most academic journals are researchers talking to researchers. We’re typically researchers talking to the community. We hold the same standards of academic rigor except we try and present that in a way that’s useful to nonacademics, and we try and publish on topics that are important to nonacademics.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More